The S&P 500 (SP500) 2025 year-end price target has been raised to 5,600, reflecting 20x price-over-earnings, by Jefferies.

Jefferies, Mizuho Financial Group, and Morgan Stanley have emerged as the leading mergers and acquisitions (M&A) financial ...

Comedian Jim Jefferies unleashes his thoughts on tiny moustaches, straight-guy struggles and why acting doesn't count as a ...

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

Investing.com -- Jefferies initiated coverage of Jefferson Capital Inc with a Buy rating and a $29 price target, pointing to the company’s differentiated tech-based model, consistent financial ...

A teen is charged with murder after he shot and killed another teen at a watermelon festival in South Carolina, according to ...

South Korean fashion retailer F&F Co said on Monday it has hired Goldman Sachs to advise on an acquisition of TaylorMade, and ...

ICICI Bank's Q1 net interest income (NII) growth slightly surpassed expectations at 1 per cent year-on-year. This was boosted ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Reliance Industries’ rapid progress towards operationalising gigafactories for its new energy business has raised analysts' ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Reliance Industries’ share price declined 2.6% to an intra-day low of Rs 1,437 on the National Stock Exchange. The stock was ...